Lewis X component in human milk binds DC-SIGN and inhibits HIV-1 transfer to CD4+ T lymphocytes

Journal of Clinical Investigation

Volumn 115, Issue 11, 2005, Pages 3256-3264

  Naarding, Marloes A ^a   Ludwig, Irene S ^b   Groot, Fedde ^a   Berkhout, Ben ^a   Geijtenbeek, Teunis B H ^b   Pollakis, Georgios ^a   Paxton, William A ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA LACTALBUMIN; BETA CASEIN; BOVINE SERUM ALBUMIN; CD209 ANTIGEN; EPITOPE; GLYCOPROTEIN GP 120; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; LACTOFERRIN; LYSOZYME; POLYACRYLAMIDE; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; STAGE SPECIFIC EMBRYO ANTIGEN 1;

ANTIGEN PRESENTATION; ARTICLE; BREAST FEEDING; BREAST MILK; CONTROLLED STUDY; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN MOTIF; RAJI CELL; T LYMPHOCYTE; VIRUS TRANSMISSION;

ANTIGENS, CD15; CD4-POSITIVE T-LYMPHOCYTES; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CELLS, CULTURED; DENDRITIC CELLS; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; LECTINS, C-TYPE; MILK, HUMAN; PROTEIN BINDING; RECEPTORS, CELL SURFACE; TRISACCHARIDES;

EID: 27644561867     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI25105     Document Type: Article

References (67)

1. Mitchell, D.A., Fadden, A.J., and Drickamer, K. 2001. A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR. Subunit organization and binding to multivalent ligands. J. Biol. Chem. 276:28939-28945.
2. Weis, W.I., Taylor, M.E., and Drickamer, K. 1998. The C-type lectin superfamily in the immune system. Immunol. Rev. 163:19-34.
3. Yu Kimata, M.T., et al. 2002. Capture and transfer of simian immunodeficiency virus by macaque dendritic cells is enhanced by DC-SIGN. J. Virol. 76:11827-11836.
4. Geijtenbeek, T.B., et al. 2000. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell. 100:587-597.
5. Pohlmann, S., et al. 2001. DC-SIGN interactions with human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus. J. Virol. 75:4664-4672.
6. Geijtenbeek, T.B., et al. 2000. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell. 100:575-585.
7. Geijtenbeek, T.B., et al. 2000. DC-SIGN-ICAM-2 interaction mediates dendritic cell trafficking. Nat. Immunol. 1:353-357.
8. Wu, L., Martin, T.D., Carrington, M., and Kewal-Ramani, V.N. 2004. Raji B cells, misidentified as THP-1 cells, stimulate DC-SIGN-mediated HIV transmission. Virology. 318:17-23.
9. Lozach, P.Y., et al. 2003. DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2. J. Biol. Chem. 278:20358-20366.
10. Pohlmann, S., et al. 2003. Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR. J. Virol. 77:4070-4080.
11. Alvarez, C.P., et al. 2002. C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans. J. Virol. 76:6841-6844.
12. Halary, F., et al. 2002. Human cytomegalovirus binding to DC-SIGN is required for dendritic cell infection and target cell trans-infection. Immunity. 17:653-664.
13. Tassaneetrithep, B., et al. 2003. DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J. Exp. Med. 197:823-829.
14. Geijtenbeek, T.B., et al. 2003. Mycobacteria target DC-SIGN to suppress dendritic cell function. J. Exp. Med. 197:7-17.
15. Maeda, N., et al. 2003. The cell surface receptor DC-SIGN discriminates between Mycobacterium species through selective recognition of the mannose caps on lipoarabinomannan. J. Biol. Chem. 278:5513-5516.
16. Tailleux, L., et al. 2003. DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells. J. Exp. Med. 197:121-127.
17. Colmenares, M., Puig-Kroger, A., Pello, O.M., Corbi, A.L., and Rivas, L. 2002. Dendritic cell (DC)-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing nonintegrin (DC-SIGN, CD209), a C-type surface lectin in human DCs, is a receptor for Leishmania amastigotes. J. Biol. Chem. 277:36766-36769.
18. Colmenares, M., Corbi, A.L., Turco, S.J., and Rivas, L. 2004. The dendritic cell receptor DC-SIGN discriminates among species and life cycle forms of Leishmania. J. Immunol. 172:1186-1190.
19. Cambi, A., et al. 2003. The C-type lectin DC-SIGN (CD209) is an antigen-uptake receptor for Candida albicans on dendritic cells. Eur. J. Immunol. 33:532-538.
20. Appelmelk, B.J., et al. 2003. Cutting edge: carbohydrate profiling identifies new pathogens that interact with dendritic cell-specific ICAM-3-grabbing nonintegrin on dendritic cells. J. Immunol. 170:1635-1639.
21. Bergman, M.P., et al. 2004. Helicobacter pylori modulates the T helper cell 1/T helper cell 2 balance through phase-variable interaction between lipopolysaccharide and DC-SIGN. J. Exp. Med. 200:979-990.
22. Hu, J., Gardner, M.B., and Miller, C.J. 2000. Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells. J. Virol. 74:6087-6095.
23. Pope, M., Gezelter, S., Gallo, N., Hoffman, L., and Steinman, R.M. 1995. Low levels of HIV-1 infection in cutaneous dendritic cells promote extensive viral replication upon binding to memory CD4+ T cells. J. Exp. Med. 182:2045-2056.
24. Reece, J.C., et al. 1998. HIV-1 selection by epidermal dendritic cells during transmission across human skin. J. Exp. Med. 187:1623-1631.
25. Rowland-Jones, S.L. 1999. HIV: the deadly passenger in dendritic cells. Curr. Biol. 9:R248-R250.
26. Blauvelt, A., et al. 1997. Productive infection of dendritic cells by HIV-1 and their ability to capture virus are mediated through separate pathways. J. Clin. Invest. 100:2043-2053.
27. Cameron, P.U., et al. 1992. Dendritic cells exposed to human immunodeficiency virus type-1 transmit a vigorous cytopathic infection to CD4+ T cells. Science. 257:383-387.
28. De Cock, K.M., et al. 2000. Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice. JAMA. 283:1175-1182.
29. Kourtis, A.P., Bulterys, M., Nesheim, S.R., and Lee, F.K. 2001. Understanding the timing of HIV transmission from mother to infant. JAMA. 285:709-712.
30. Nduati, R., et al. 2000. Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA. 283:1167-1174.
31. Rousseau, C.M., et al. 2003. Longitudinal analysis of human immunodeficiency virus type 1 RNA in breast milk and of its relationship to infant infection and maternal disease. J. Infect. Dis. 187:741-747.
32. Miotti, P.G., et al. 1999. HIV transmission through breastfeeding: a study in Malawi. JAMA. 282:744-749.
33. Lewis, P., et al. 1998. Cell-free human immunodeficiency virus type 1 in breast milk. J. Infect. Dis. 177:34-39.
34. Dawarkadas, A.M., Saha, K., and Mathur, N.B. 1991. A comparative study of cells and anti-microbial proteins in colostrum of mothers delivering pre- and full-term babies. J. Trop. Pediatr. 37:214-219.
35. van't Wout, A.B., et al. 1994. Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission. J. Clin. Invest. 94:2060-2067.
36. Zhu, T., et al. 1993. Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science. 261:1179-1181.
37. Toniolo, A., et al. 1995. Productive HIV-1 infection of normal human mammary epithelial cells. AIDS. 9:859-866.
38. Messaoudi, K.E., et al. 2000. A human milk factor susceptible to cathepsin D inhibitors enhances human immunodeficiency virus type 1 infectivity and allows virus entry into a mammary epithelial cell line. J. Virol. 74:1004-1007.
39. Riley, J.L., et al. 1998. Naive and memory CD4 T cells differ in their susceptibilities to human immunodeficiency virus type 1 infection following CD28 costimulation: implications for transmission and pathogenesis. J. Virol. 72:8273-8280.
40. Bleul, C.C., Wu, L., Hoxie, J.A., Springer, T.A., and Mackay, C.R. 1997. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc. Natl. Acad. Sci. U. S. A. 94:1925-1930.
41. Cameron, P.U., et al. 1996. The interaction of macrophage and non-macrophage tropic isolates of HIV-1 with thymic and consular dendritic cells in vitro. J. Exp. Med. 183:1851-1856.
42. Stahl-Hennig, C., et al. 1999. Rapid infection of oral mucosal-associated lymphoid tissue with simian immunodeficiency virus. Science. 285:1261-1265.
43. Choi, Y.K., Whelton, K.M., Mlechick, B., Murphey-Corb, M.A., and Reinhart, T.A. 2003. Productive infection of dendritic cells by simian immunodeficiency virus in macaque intestinal tissues. J. Pathol. 201:616-628.
44. Berkhout, B., et al. 2002. Characterization of the anti-HIV effects of native lactoferrin and other milk proteins and protein-derived peptides. Antiviral Res. 55:341-355.
45. Harmsen, M.C., et al. 1995. Antiviral effects of plasma and milk proteins: lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro. J. Infect. Dis. 172:380-388.
46. Swart, P.J., et al. 1996. Antiviral effects of milk proteins: acylation results in polyanionic compounds with potent activity against human immunodeficiency virus types 1 and 2 in vivo. AIDS Res. Hum. Retroviruses. 12:769-775.
47. Lee-Huang, S., et al. 1999. Lysozyme and RNases as anti-HIV components in beta-core preparations of human chorionic gonadotropin. Proc. Natl. Acad. Sci. U. S. A. 96:2678-2681.
48. McNeely, T.B., et al. 1997. Inhibition of human immunodeficiency virus type 1 infectivity by secretory leukocyte protease inhibitor occurs prior to viral reverse transcription. Blood. 90:1141-1149.
49. McNeely, T.B., et al. 1995. Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro. J. Clin. Invest. 96:456-464.
50. Chaturvedi, P., Warren, C.D., Ruiz-Palacios, G.M., Pickering, L.K., and Newburg, D.S. 1997. Milk oligosaccharide profiles by reversed-phase HPLC of their perbenzoylated derivatives. Anal. Biochem. 251:89-97.
51. Kobata, A., Ginsburg, V., and Tsuda, M. 1969. Oligosaccharides of human milk. I. Isolation and characterization. Arch. Biochem. Biophys. 130:509-513.
52. Stahl, B., et al. 1994. Oligosaccharides from human milk as revealed by matrix-assisted laser desorption/ionization mass spectrometry. Anal. Biochem. 223:218-226.
53. Schwertmann, A., Rudloff, S., and Kunz, C. 1996. Potential ligands for cell adhesion molecules in human milk. Ann. Nutr. Metab. 40:252-262.
54. Van Die., I., et al. 2003. The dendritic cell-specific C-type lectin DC-SIGN is a receptor for Schistosoma mansoni egg antigens and recognizes the glycan antigen Lewis x. Glycobiology 13:471-478.
55. Newburg, D.S. 1996. Oligosaccharides and glycoconjugates in human milk: their role in host defense. J. Mammary Gland Biol. Neoplasia. 1:271-283.
56. Geijtenbeek, T.B., et al. 2002. Identification of different binding sites in the dendritic cell-specific receptor DC-sIGN for ICAM-3 and HIV-1. J. Biol. Chem. 277:11314-11320.
57. Bashirova, A.A., et al. 2001. A dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN)-related protein is highly expressed on human liver sinusoidal endothelial cells and promotes HIV-1 infection. J. Exp. Med. 193:671-678.
58. Groot, F., et al. 2005. Lactoferrin prevents dendritic cell-mediated human immunodeficiency virus type 1 transmission by blocking the DC-SIGN-gp120 interaction. J. Virol. 79:3009-3015.
59. Guo, Y., et al. 2004. Structural basis for distinct ligand-binding and targeting properties of the receptors DC-SIGN and DC-SIGNR. Nat. Struct. Mol. Biol. 11:591-598.
60. Sanders, R.W., et al. 2002. Differential transmission of human immunodeficiency virus type 1 by distinct subsets of effector dendritic cells. J. Virol. 76:7812-7821.
61. Turville, S.G., et al. 2001. HIV gp120 receptors on human dendritic cells. Blood. 98:2482-2488.
62. Van Liempt, E., et al. 2004. Molecular basis of the differences in binding properties of the highly related C-type lectins DC-SIGN and L-SIGN to Lewis X trisaccharide and Schistosoma mansoni egg antigens. J. Biol. Chem. 279:33161-33167.
63. Su, S.V., et al. 2004. DC-SIGN binds to HIV-1 glycoprotein 120 in a distinct but overlapping fashion compared with ICAM-2 and ICAM-3. J. Biol. Chem. 279:19122-19132.
64. Okano, M., Satoskar, A.R., Nishizaki, K., and Harn, D.A., Jr. 2001. Lacto-N-fucopentaose III found on Schiscosoma mansoni egg antigens functions as adjuvant for proteins by inducing Th2-type response. J. Immunol. 167:442-450.
65. Pabst, H.F., et al. 1997. Differential modulation of the immune response by breast- or formula-feeding of infants. Acta-Paediatr. 86:1291-1297.
66. Roos, J.W., Maughan, M.F., Liao, Z., Hildreth, J.E., and Clements, J.E. 2000. LuSIV cells: a reporter cell line for the detection and quantitation of a single cycle of HIV and SIV replication. Virology. 273:307-315.
67. Pollakis, G., et al. 2001. N-linked glycosylation of the HIV type-1 gp120 envelope glycoprotein as a major determinant of CCR5 and CXCR4 coreceptor utilization. J. Biol. Chem. 276:13433-13441.